DRREDDY Dr Reddy's Laboratories Ltd Company Mergers Announcement 2023 - Collaboration for ALS treatment Dr. Reddys Laboratories and Coya Therapeutics enter into an exclusive collaboration for the development and commercialization of COYA 302, an investigational combination therapy for the treatment of Amyotrophic Lateral Sclerosis (ALS)..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Dr Reddy's Laboratories Ltd